普罗布考联合辛伐他汀对急性冠脉综合征患者颈动脉内膜中层厚度及血管内皮功能的影响(3)
 |
| 第1页 |
参见附件(2065KB，3页)。
[2] Celermajer DS.Brachial artery FMD with 5-minute distal cuff occlusion--a useful pathophysiological test after all!J Appl Physiol,2005,99(4):1619.
[3] Holaj R,Spácil J,Petrásek J.Relation of the thickness of the intima and media of the common carotid artery,atherosclerotic plaque in the carotids and manifestations of atherosclerosis in the vessels of the lower extremity in comparison to coronary atherosclerosis.Cas Lek Cesk,1998,137(23):716-720.
[4] Spence JD.Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease.Am J Cardiol,2002,89(4A):10B-15B; discussion 15B-16B.
[5] Kaesemeyer WH,Caldwell RB,Huang JZ,et al.Pravastatin sodiumactivates endothelialnitric oxide synthase independent of its cholesterol loweringactions.J Am Coll Cardiol,1999,33(1):234-241.
[6] Rikitake Y,Liao JK.Rho GTPases,statins,and nitric oxide.Circ Res,2005,97(12):1232-1235.
[7] 孟晓萍,王超,孙健,等.急性冠脉综合征患者血清基质金属蛋白酶(MMP2 、MMP9)的表达.中国动脉硬化杂志,2006,14(4):339-342.
[8] 郝冰,孟晓萍,杨东华,等.普罗布可对冠心病患者血清中MMP-2 的抑制作用.吉林大学学报(医学版),2007,33(3):559-561.
[9] 张园园,张运,张梅,等.舒降之、普罗布考、开搏通和祛淤消斑胶囊对食饵性兔动脉粥样硬化血管内皮舒缩功能的影响.中国动脉硬化杂志,2003,11:118-122.
您现在查看是摘要介绍页，详见PDF附件(2065KB，3页)。